Gunderson Dettmer represented client Overtime, a sports media company, in its $80 million Series C financing from investors including Jeff Bezos, Drake, Reddit co-founder Alexis Ohanian and several National Basketball Association players.
Gunderson Dettmer advised client TuSimple, a San Diego-based global self-driving technology company, on its initial public offering which raised $1.35 billion with almost 34 million shares at a price to the public of $40.00 per share.
Gunderson Dettmer represented client Medrio, a leading provider of eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets, in its acquisition of HMD Clinical.
2021年4月15日，自动驾驶卡车公司图森未来（TuSimple Holdings Inc.）宣布在美国纳斯达克全球精选市场成功上市，股票代码“TSP”，发行价为40美元每股，公司募集资金总额超过10亿美元，成为“全球自动驾驶第一股”。
Gunderson Dettmer represented client Dragoneer and Greenoaks Capital as they led the $325 million Series E financing of Scale AI, a San Francisco-based startup that specializes in helping companies label and curate data for artificial intelligence applications.
Gunderson Dettmer represented client Jungle Ventures as it led the $2.6 million pre-Series A financing of Dat Bike, an electric motorbike company in Southeast Asia.
Gunderson Dettmer represented client Carta Healthcare, a provider of AI-powered clinical data abstraction technology and services, in its $17.3 million Series A financing led by Storm Ventures.
Gunderson Dettmer represented client Prosus Ventures as it co-led the $350 million Series E financing of API Holdings, the parent company of Pharmeasy, one of India’s largest digital pharmacies, along with private equity firm TPG Growth.
Gunderson Dettmer represented client Kavak, an online platform for buying and selling secondhand cars, in its $485 million Series D financing, bringing the company’s valuation to $4 billion.
Gunderson Dettmer represented client Anduril Industries, a defense technology provider, in its acquisition of Area-I.
Gunderson Dettmer represented clients Lightspeed Venture Partners and SoftBank Ventures in the $17 million Series A financing of Endowus, a digital wealth advisor based in Singapore.
Gunderson Dettmer represented client Betty Labs, a tech startup that created Locker Room, a live audio app for sports fans, in its acquisition by Spotify.
Gunderson Dettmer represented client Tonal, a smart at-home fitness platform, in its $250 million Series E financing led by Dragoneer.
Gunderson Dettmer represented client Amgen Inc (NASDAQ:AMGN) in its acquisition of Rodeo Therapeutics.
Gunderson Dettmer represented client Pyxis Oncology, a developer of antibody therapeutics to further improve the outcome for patients with cancer, in its $152 million Series B financing co-led by Arix Bioscience and RTW Investments.
Gunderson Dettmer represented client Cityblock Health, a startup improving health care for low-income patients with complex medical needs, in its $192 million Series C-2 financing led by Tiger Global.
Gunderson Dettmer represented client Tarsus Pharmaceuticals, Inc., a late clinical-stage biopharmaceutical company, in its strategic partnership with LianBio to develop and commercialize its investigational therapeutic for eye conditions, TP-03, in Greater China.
Gunderson Dettmer represented client Khatabook, an India-based fintech company, in its $10 million acquisition of Biz Analyst, a software-as-a-service business management firm.
Gunderson Dettmer represented client MaC Venture Capital in the formation of its $110 million inaugural fund.
Gunderson Dettmer represented client Greenoaks as it led a $100 million extension of the Series D round of Airwallex, a fintech payments unicorn that serves cross-border businesses, taking Airwallex’ valuation to $2.6 billion.
Gunderson Dettmer represented client Dataminr, a real-time AI platform for event and risk detection, in its $475 million Series F financing.
Gunderson Dettmer represented Resolve Growth Partners in the formation of its inaugural funds, Resolve Growth Partners Fund I, L.P. and Resolve Growth Partners Fund I-B, L.P.
Gunderson Dettmer represented client Boston Pharma, a clinical stage biopharmaceutical company developing differentiated therapeutics, in its strategic license arrangement with GSK.
Gunderson Dettmer represented client Corvus Insurance, a leading provider of smart commercial insurance products powered by AI-driven risk data, in its $100 million Series C financing led by Insight Partners.
Gunderson Dettmer represented clients Sequoia India, Lightspeed India and Greenoaks as co-investors in the $12.5 million Series B financing of Apna.co, a vertical professional networking platform.
Gunderson Dettmer represented client Turntide Technologies, an electric motor system with digital DNA, in its acquisition of Riptide.
Gunderson Dettmer represented Foresite Capital in the formation of the fund’s fifth fund, which is comprised of two separate investment vehicles, Foresite Capital Fund V and Foresite Capital Opportunity Fund V.
Gunderson Dettmer represented client Newsela, a SaaS platform for K-12 instructional material, in its $100 million Series D financing led by Franklin Templeton.
Gunderson Dettmer represented client Xencor, a clinical-stage biopharmaceutical company, in its partnership agreement with UCLA’s Technology Development Group to develop new drugs.
Gunderson Dettmer represented client Aviatrix, a cloud network platform, in its $75 million Series D financing led by General Catalyst.
- Page 1 of 14